2020
DOI: 10.1097/cce.0000000000000295
|View full text |Cite
|
Sign up to set email alerts
|

Endothelial Biomarkers Are Associated With Indirect Lung Injury in Sepsis-Associated Pediatric Acute Respiratory Distress Syndrome

Abstract: Supplemental Digital Content is available in the text.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 18 publications
(24 citation statements)
references
References 48 publications
(38 reference statements)
0
21
0
Order By: Relevance
“…This imbalance has been found in ARDS [145]. A four-endothelial biomarker panel, including elevated angiopoietin-2/angiopoietin-1 ratio, vascular cell-adhesion molecule, and von Willebrand factor, is useful in identifying acute respiratory distress syndrome [146].…”
Section: Idiopathic Pneumonia Syndrome (Ips)mentioning
confidence: 95%
“…This imbalance has been found in ARDS [145]. A four-endothelial biomarker panel, including elevated angiopoietin-2/angiopoietin-1 ratio, vascular cell-adhesion molecule, and von Willebrand factor, is useful in identifying acute respiratory distress syndrome [146].…”
Section: Idiopathic Pneumonia Syndrome (Ips)mentioning
confidence: 95%
“…1). mortality in pediatric ARDS related to sepsis, 33 but has not been examined in the cardiac arrest population. In adult patients with chronic heart failure, sRAGE has been shown to be associated with mortality, is sensitive, and independent of other heart failure scores based on clinical and standard laboratory data.…”
Section: Mortality In the Ards + Ca Subgroupmentioning
confidence: 99%
“…For example, the role of cell-free hemoglobin (CFH) as a mediator of sepsis-related organ dysfunction is the basis of ongoing investigation in patients with ARDS due to sepsis. Although sepsis is itself a heterogeneous syndrome, the underlying pathobiology of patients with sepsis-related ARDS may differ from patients with ARDS from other causes, especially in the case of extrapulmonary sepsis [ 33 , 34 ]. Targeting patients with sepsis for testing new therapies is a promising enrichment strategy for ARDS clinical trials.…”
Section: Introductionmentioning
confidence: 99%